1999 to 2018 saw increase in cancer survivors with functional limitation, finds research

by Elana GotkineFrom 1999 to 2018, there was a more than twofold increase in the number of cancer survivors reporting functional limitations, according to a research letter published online May 11 in&

Updated on: January 23,2024 10

1999 to 2018 saw increase in cancer survivors with functional limitation, finds research

by Elana GotkineFrom 1999 to 2018, there was a more than twofold increase in the number of cancer survivors reporting functional limitations, according to a research letter published online May 11 in&

Updated on:January 23,2024 10

Early findings suggest clinical and lab-based approach critical to tracking head and neck cancer recurrence

by Anna Megdell,University of MichiganSurvival over time. (A)Median overall survival (mOS) plotted over years of the study. (B)mOS improved from 1998 to 2007 to 2008–2019. (C)m

Updated on: January 30,2024 11

Early findings suggest clinical and lab-based approach critical to tracking head and neck cancer recurrence

by Anna Megdell,University of MichiganSurvival over time. (A)Median overall survival (mOS) plotted over years of the study. (B)mOS improved from 1998 to 2007 to 2008–2019. (C)m

Updated on:January 30,2024 11

Platinum-based chemotherapy distribution within a tumor may predict ovarian cancer treatment resistance

byNagoya UniversityTumor tissue is indicated with the filled arrow and stroma with the unfilled arrow (upper photo).A platinum-resistant patient showing platinum (blue in the bottom photo) mostl

Updated on: January 22,2024 19

Platinum-based chemotherapy distribution within a tumor may predict ovarian cancer treatment resistance

byNagoya UniversityTumor tissue is indicated with the filled arrow and stroma with the unfilled arrow (upper photo).A platinum-resistant patient showing platinum (blue in the bottom photo) mostl

Updated on:January 22,2024 19

A sustainable diagnosis tool for multiple cancers

byNature Publishing GroupValidation via cancers diagnosis. Credit:Nature Sustainability(2024). DOI: 10.1038/s41893-024-01323-9An accurate, affordable, environmentally and user-friend

Updated on: April 28,2024 0

A sustainable diagnosis tool for multiple cancers

byNature Publishing GroupValidation via cancers diagnosis. Credit:Nature Sustainability(2024). DOI: 10.1038/s41893-024-01323-9An accurate, affordable, environmentally and user-friend

Updated on:April 28,2024 0

Dosing regimen for an old cancer drug shows new promise as an immunotherapy

by Bendta Schroeder,Massachusetts Institute of TechnologyA cancer cell (blue, center) can elude attack by immune cells (such as these T cells shown in green and red) by sequestering the mutated

Updated on: May 20,2024 7

Dosing regimen for an old cancer drug shows new promise as an immunotherapy

by Bendta Schroeder,Massachusetts Institute of TechnologyA cancer cell (blue, center) can elude attack by immune cells (such as these T cells shown in green and red) by sequestering the mutated

Updated on:May 20,2024 7

Study links poverty to increased acute lymphoblastic leukemia relapse

by Brianna Hoge,University of Alabama at BirminghamCredit: Pixabay/CC0 Public DomainA new study from the University of Alabama at Birmingham's Marnix E. Heersink School of Medicine suggests

Updated on: January 22,2024 11

Study links poverty to increased acute lymphoblastic leukemia relapse

by Brianna Hoge,University of Alabama at BirminghamCredit: Pixabay/CC0 Public DomainA new study from the University of Alabama at Birmingham's Marnix E. Heersink School of Medicine suggests

Updated on:January 22,2024 11

Research could lead to more precise diagnosis and treatment of ovarian cancer

by Michael Brown,University of Alberta Faculty of Medicine & DentistryLynne Postovit co-led a new study identifying eight biomarkers that enable pathologists to differentiate between two typ

Updated on: June 28,2024 8

Research could lead to more precise diagnosis and treatment of ovarian cancer

by Michael Brown,University of Alberta Faculty of Medicine & DentistryLynne Postovit co-led a new study identifying eight biomarkers that enable pathologists to differentiate between two typ

Updated on:June 28,2024 8

New immune system understanding may help doctors target cancer

by Garth Sundem,CU Anschutz Medical CampusPaul Norman, PhD. Credit: University of Colorado Cancer CenterYour immune system's natural killer cells recognize and attack two major kinds of dang

Updated on: March 12,2024 11

New immune system understanding may help doctors target cancer

by Garth Sundem,CU Anschutz Medical CampusPaul Norman, PhD. Credit: University of Colorado Cancer CenterYour immune system's natural killer cells recognize and attack two major kinds of dang

Updated on:March 12,2024 11

Altered cell behavior behind resistance in neuroblastoma

byLund UniversityEstablishment and application of a COJEC-like treatment protocol using NB PDX models.(A) Schematic representation of the experimental design. Mice were injected subcutaneously (

Updated on: January 04,2024 6

Altered cell behavior behind resistance in neuroblastoma

byLund UniversityEstablishment and application of a COJEC-like treatment protocol using NB PDX models.(A) Schematic representation of the experimental design. Mice were injected subcutaneously (

Updated on:January 04,2024 6

Predicting condensate formation by cancer-associated fusion oncoproteins

bySt. Jude Children's Research HospitalOverview of the fusion oncoprotein (FO) database (FOdb). Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-41655-2Many cancers ar

Updated on: January 07,2024 9

Predicting condensate formation by cancer-associated fusion oncoproteins

bySt. Jude Children's Research HospitalOverview of the fusion oncoprotein (FO) database (FOdb). Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-41655-2Many cancers ar

Updated on:January 07,2024 9

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring and treatment

byIndiana UniversityIU School of Medicine's Spyridon Bakas said the new recommendations are a much-needed update to the current standard of care in which individual radiologists measure tumo

Updated on: December 01,2024 0

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring and treatment

byIndiana UniversityIU School of Medicine's Spyridon Bakas said the new recommendations are a much-needed update to the current standard of care in which individual radiologists measure tumo

Updated on:December 01,2024 0

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on: January 23,2024 14

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on:January 23,2024 14